MedMesh.i
Corpus
Accueil
Racine
Corpus
Exploration
Accueil
Racine
Accueil

Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Drug Repositioning »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Prescriptions < Drug Repositioning < Drug Resistance  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 129.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000031 (2021) Albert Prats-Uribe ; Anthony G. Sena ; Lana Yin Hui Lai ; Waheed-Ul-Rahman Ahmed ; Heba Alghoul ; Osaid Alser ; Thamir M. Alshammari ; Carlos Areia ; William Carter ; Paula Casajust ; Dalia Dawoud ; Asieh Golozar ; Jitendra Jonnagaddala ; Paras P. Mehta ; Mengchun Gong ; Daniel R. Morales ; Fredrik Nyberg ; Jose D. Posada ; Martina Recalde ; Elena Roel ; Karishma Shah ; Nigam H. Shah ; Lisa M. Schilling ; Vignesh Subbian ; David Vizcaya ; Lin Zhang ; Ying Zhang ; Hong Zhu ; Li Liu ; Jaehyeong Cho ; Kristine E. Lynch ; Michael E. Matheny ; Seng Chan You ; Peter R. Rijnbeek ; George Hripcsak ; Jennifer Ce Lane ; Edward Burn ; Christian Reich ; Marc A. Suchard ; Talita Duarte-Salles ; Kristin Kostka ; Patrick B. Ryan ; Daniel Prieto-AlhambraUse of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
000258 (2021) Fabio Cruciani ; Laura Amato ; Franco De Crescenzo ; Zuzana Mitrova ; Rosella Saulle ; Simona Vecchi ; Marina Davoli[The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000272 (2021) Seongman Bae ; Byeongzu Ghang ; Ye-Jee Kim ; Joon Seo Lim ; Sung-Cheol Yun ; Yong-Gil Kim ; Sang-Oh Lee ; Sung-Han KimRecent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
000274 (2021) Markus Blaess ; Lars Kaiser ; Oliver Sommerfeld ; René Csuk ; Hans-Peter DeignerDrugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
000325 (2021) Masashi Ohe ; Ken Furuya ; Houman GoudarziMultidrug treatment for COVID-19.
000387 (2021) Giulia Fiscon ; Federica Conte ; Lorenzo Farina ; Paola PaciSAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
000393 (2021) Sawsan Elgohary ; Aya A. Elkhodiry ; Nada S. Amin ; Ulrike Stein ; Hend M. El TayebiThymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
000454 (2021) S. Rakedzon ; A. Neuberger ; A J Domb ; N. Petersiel ; E. SchwartzFrom hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
000480 (2021) Florence Rodgers ; Toby Pepperrell ; Sarai Keestra ; Victoria PilkingtonMissing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
000508 (2021) Dingzhong Li ; Jianbing Hu ; Dian Li ; Weijun Yang ; Shuang-Feng Yin ; Renhua QiuReviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19.
000516 (2021) Shweta A. More ; Akshay S. Patil ; Nikhil S. Sakle ; Santosh N. MokaleNetwork analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
000527 (2021) Philippe Gautret ; Jean-Christophe Lagier ; Stéphane Honoré ; Van Thuan Hoang ; Didier RaoultClinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
000528 (2021) Guogen Shan ; Weizhen WangAdvanced statistical methods and designs for clinical trials for COVID-19.
000530 (2021) Philippe Colson ; Bernard La Scola ; Jean-Christophe Lagier ; Philippe Gautret ; Didier RaoultInterpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
000531 (2021) Philippe Gautret ; Van Thuan Hoang ; Jean-Christophe Lagier ; Didier RaoultEffect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
000533 (2021) Tuan V. NguyenUncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
000534 (2021) Philippe Gautret ; Stéphane Honoré ; Jean-Christophe Lagier ; Didier RaoultSafety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000535 (2021) Mohamed O. SaadLetter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000536 (2021) Marcelo Rodrigues Dos SantosReferring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
000537 (2021) Carlos Gustavo WambierFocus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000538 (2021) Jason D. Goldman ; George Diaz ; Walter J. UrbaUse of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Drug Repositioning" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Drug Repositioning" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Repositioning
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021